High potency glucocorticoid polymorphs, methods of making and uses thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ZHEJIANG PALOALTO PHARMA TECH CO LTD
- Filing Date
- 2024-12-09
- Publication Date
- 2026-06-09
AI Technical Summary
Existing glucocorticoids have many side effects and insensitivity problems when treating inflammation and autoimmune diseases, especially when used at high doses, which lead to diabetes, osteoporosis, etc., and some patients are resistant to drugs, affecting the treatment effect.
A highly potent and highly selective glucocorticoid polymorph, including crystal forms K, A, C, E, F, I, L, were developed, and polymorphs with specific XRPD and DSC patterns were obtained by specific preparation methods such as suspension stirring and filtration in different solvents.
Reduces side effects during the treatment process, improves therapeutic effect, achieves the same therapeutic effect at low doses, and improves the bioavailability and stability of the drug.
Smart Images

Figure CN122180697A_ABST